Related Experiment Video
Updated: Apr 26, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI
Nandinee Fariah Haq1, Piotr Kozlowski1, Edward C Jones1
1University of British Columbia, Vancouver, BC, Canada.
This study introduces a novel data-driven approach for prostate cancer detection using dynamic contrast-enhanced MRI (DCE-MRI). The method analyzes image time series without pharmacokinetic modeling, outperforming traditional parameters in accuracy.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is crucial for prostate cancer diagnosis and staging.
- Current DCE-MRI analysis relies on pharmacokinetic models that often oversimplify perfusion and require challenging arterial input function estimation.
- Limitations in existing models necessitate more robust methods for accurate prostate cancer characterization.
Purpose of the Study:
- To develop and validate a data-driven approach for prostate cancer detection using DCE-MRI data.
- To evaluate the efficacy of model-free empirical parameters and principal component analysis (PCA) features against traditional pharmacokinetic parameters.
- To improve multiparametric MRI protocols for enhanced prostate cancer detection.
Main Methods:
- A data-driven analysis of DCE-MRI time series was performed, bypassing traditional pharmacokinetic modeling.
- Model-free empirical parameters and PCA of normalized T1-weighted intensities were extracted as features.
- Least absolute shrinkage and selection operator (LASSO) regression identified optimal principal components, and a support vector machine classifier was used for detection.
Main Results:
- The proposed data-driven approach achieved an area under the ROC curve of 0.86.
- This performance surpasses the 0.78 AUC obtained with traditional pharmacokinetic parameters.
- Validation was conducted on 449 tissue regions from 16 patients, with results correlated to histological evaluations.
Conclusions:
- The novel data-driven method using LASSO-isolated PCA parameters shows superior performance in prostate cancer detection compared to conventional pharmacokinetic parameters.
- This approach offers a promising alternative for analyzing DCE-MRI data, potentially enhancing multiparametric MRI protocols.
- The findings suggest a significant advancement in non-invasive prostate cancer diagnosis and staging.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
15:48Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014